ARISE - Aggressive Reduction of Inflammation Stops Events
NCT00066898
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
6000
Enrollment
INDUSTRY
Sponsor class
Conditions
Atherosclerosis
Coronary Artery Disease
Myocardial Infarction
Unstable Angina
Interventions
DRUG:
AGI-1067
Sponsor
AtheroGenics